Can peritoneal carcinomatosis of colorectal origin be treated with oral everolimus alone or in combination with capecitabine? Preliminary results

Yuksel M. E., YÜKSEL O.

ROMANIAN JOURNAL OF MILITARY MEDICINE, cilt.124, sa.4, ss.518-524, 2021 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 124 Sayı: 4
  • Basım Tarihi: 2021
  • Dergi Adı: ROMANIAN JOURNAL OF MILITARY MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
  • Sayfa Sayıları: ss.518-524
  • Anahtar Kelimeler: colon cancer, everolimus, peritoneal carcinomatosis, MTOR INHIBITOR EVEROLIMUS, PHASE-I, MAMMALIAN TARGET, CANCER, CHEMOTHERAPY, MODEL
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: We wanted to evaluate the effectiveness of oral everolimus alone and in combination with capecitabine treatment on colorectal cancer-induced peritoneal carcinomatosis animal model.